Tag: CLTI

PAD: R3 Vascular reports ‘successful initiation’ of first-in-human study of bioresorbable...

Medical device developer R3 Vascular has reported the "successful initiation" of a first-in-human clinical study evaluating the technical and clinical performance of its Magnitude...

VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism

A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional...

Veterans with claudication who undergo revascularization ‘significantly more likely to have...

Patients within the Veterans Affairs Administration healthcare system who underwent an intervention for intermittent claudication (IC) were consistently at three-to-four times greater risk of...

PRISTINE registry with Selution SLR sirolimus drug-eluting balloon completes enrollment

MedAlliance has announced completion of patient enrollment in the PRISTINE clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of patients with below-the-knee...

LimFlow system a ‘cost-effective and high-value alternative’ to traditional therapies

Percutaneous deep vein arterialization (pDVA) with the LimFlow system offers a cost-effective and high-value alternative to traditional therapies or amputation, according to a recent...

Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception

“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons in the peripheral arteries,” findings from a systematic review...

Introducing patient-reported outcomes into the VQI

Vascular specialists have long recognized that there is more to the treatment of peripheral arterial disease (PAD) than the immediate procedural success and early...

Philips announces positive two-year data from TOBA II BTK clinical trial

Royal Philips recently announced positive two-year results from the TOBA (Tack optimized balloon angioplasty) II below-the-knee (BTK) clinical trial. The data show the Philips Tack endovascular...

One-year results from PROMISE I study of LimFlow system in ‘no-option’...

Twelve-month data from the full patient cohort in the PROMISE I study of the LimFlow percutaneous deep vein arterialization (pDVA) system have been...

Intermittent claudication and exercise therapy: A poor SET-up

Many of you may have already heard about the controversial Comparative Billing Reports (CBRs) that have been received by some of our vascular surgery...

Innovation: ISET audience hears what’s on the horizon for CLTI patients

“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider, MD, professor of vascular and endovascular surgery...

MicroStent to treat PAD below the knee receives FDA breakthrough device...

Micro Medical Solutions (MMS) recently revealed Food and Drug Administration (FDA) breakthrough device designation for its MicroStent vascular stent. This novel technology is designed...

Lessons in PAD care from VA vascular surgeons

The care of patients with peripheral arterial disease (PAD) is challenging and costly. Every practicing vascular surgeon knows that when patients present with ulcerations,...

‘A reliable tool’: Positive findings for 2D perfusion angiography in CLTI...

Researchers suggest that in patients with chronic limb-threatening ischemia (CLTI), two-dimensional (2D) perfusion angiography is a “reliable tool” when used according to standardized methods. Jetty...

Study identifies ‘critical need’ for guidelines on appropriate use of atherectomy

No data currently exist to support the use of atherectomy over other procedures for the treatment of peripheral arterial disease (PAD), and the healthcare...

Patients with depression ‘less likely’ to go home after CLTI revascularization

A recent analysis established an association between depression and non-home discharge after revascularization for chronic limb-threatening ischemia (CLTI)—providing further evidence, the authors say, that...

WIfI score found to be accurate across racial groups

The wound, ischemia and foot infection (WIfI) score is as accurate a predictor of risk for limb loss in Black people as it is...

SWEDEPAD unplanned interim analysis shows no difference in all-cause mortality for...

An unplanned interim analysis of the registry-based SWEDEPAD clinical trial, in which patients with peripheral arterial disease (PAD) received treatment with paclitaxel-coated (drug-coated balloons...

The benefits of an academic research career in the VA

Every year a number of graduating vascular trainees look for jobs in academic surgery to develop a career as a surgeon-scientist in basic, translational...

SVS pushes out trio of mobile apps to aid CLTI treatment

The Society for Vascular Surgery (SVS) has launched three new mobile apps to help guide surgeons in the treatment and management of chronic limb-threatening...

Foot vein arterialization study shows 77.8% limb salvage rate

Foot vein arterialization (FVA) is a safe procedure with good early graft patency and a limb salvage rate of 77.8%, Qi Yan, MD, and...

Diabetes Awareness Month: The utility of SVS branding fliers for diabetic...

November is Diabetes Awareness Month. The Branding Toolkit can help SVS members promote the valuable care they provide those with the disease. One of...

Previously described patient-centered clinical success measure after revascularization for diabetic foot...

Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest...

Utilize new SVS Branding Toolkit

The new SVS Branding Toolkit—a robust set of tools designed to help members communicate their roles in comprehensive vascular care—is now available exclusively and...

CDC codifies CLI, CLTI in ICD-10-CM

The Centers for Disease Control and Prevention (CDC) has approved a proposal to distinctly recognize critical limb ischemia (CLI) and critical limb-threatening ischemia (CLTI)...

VA system delivers high quality services for veterans

Vascular surgery in the Veterans Health Administration has always been a robust service, developing into a mature specialty around the time of the Vietnam...

Medicare reimbursement fails to adequately cover cost of care after open...

For most patients with chronic limb-threatening ischemia (CLTI), Medicare reimbursement for lower extremity bypass surgery does not adequately account for case complexity in the...

‘Rapid reduction’ in amputations follows opening of multidisciplinary limb preservation service

A multidisciplinary limb preservation service under the leadership of vascular surgery in a level one trauma center was associated with an immediate and rapid...

Three weeks remain of VQI virtual sessions

SVS ONLINE—the virtual meeting staged by the Society for Vascular Surgery (SVS)—may be completed, but the Vascular Quality Initiative (VQI) virtual sessions have three...

Positive two-year data from ALPS registry of LimFlow system published

LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialization (pDVA) system. Results were published...

Quality: Global Vascular Guidelines pocket guide coming soon

The Global Vascular Guidelines (GVG), extensively researched and written by an international committee of leading vascular experts, will soon be available as a pocket...

Study: Link between IC revascularization and progression to CLTI established alongside...

PALM BEACH, Fla.—Revascularization of intermittent claudication (IC) patients is associated with an increased rate of progression to critical limb-threatening ischemia (CLTI)—as well as an...

New meta-analysis finds ‘no observed difference’ in mortality between paclitaxel and...

February 2020 brings another paclitaxel device meta-analysis of randomized controlled trials in chronic limb-threatening ischemia (CLTI) patients. Krystal Dinh, BMed, of Westmead Hospital, Sydney,...
Richard Neville

Global vascular guidelines for CLTI are gaining traction but work remains...

The application of new global vascular guidelines for chronic limb-threatening ischemia (CLTI) provides an opportune and worthwhile window to revisit the concept of critical...